Recent Events & Catalysts
BioCryst Pharmaceuticals, Inc. (BCRX) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
RBC Capital Maintains Outperform on BioCryst Pharma, Lowers Price Target to $13
Benzinga · 5d ago
Wedbush Maintains Outperform on BioCryst Pharma, Lowers Price Target to $20
Benzinga · 5d ago
BioCryst Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha · 5d ago
BioCryst Pharmaceuticals (NASDAQ:BCRX) Surges on Q2 Earnings Beat
ChartMill · 6d ago
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2026 Earnings Call Transcript
SeekingAlpha · 6d ago
BioCryst Pharma Affirms FY2026 Sales Guidance of $635.000M-$660.000M vs $666.201M Est
Benzinga · 6d ago
SEC Filings (90 days)
Results of operations (earnings release), Regulation FD disclosure, Financial statements and exhibits
Filed 2026-08-05 · 6d ago · Material
Costs associated with exit or disposal (restructuring)
Filed 2026-08-04 · 7d ago
Costs associated with exit or disposal (restructuring), Regulation FD disclosure, Financial statements and exhibits
Filed 2026-06-29 · 43d ago
Departure/appointment of directors or officers, Submission of matters to a vote of security holders, Financial statements and exhibits
Filed 2026-06-12 · 60d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.